<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">SARS-CoV nonstructural protein (Nsp) 2, for example, interacts with PHB1 and 2 and thereby impairs intracellular signaling and mitochondrial biogenesis (
 <xref rid="bib22" ref-type="bibr">Cornillez-Ty et al., 2009</xref>; 
 <xref rid="bib111" ref-type="bibr">Tatsuta and Langer, 2017</xref>) as well as MAVS (
 <xref rid="bib128" ref-type="bibr">Yoshinaka et al., 2019</xref>). Open reading frame 3b (ORF3b) inhibits type I interferon induction and thus antiviral defense via interaction with the mitochondrial virus-detecting protein RIG-1 (
 <xref rid="bib33" ref-type="bibr">Freundt et al., 2009</xref>). ORF8b of SARS-CoV has been shown to robustly activate the NLRP3 inflammasome (
 <xref rid="bib98" ref-type="bibr">Shi et al., 2019</xref>). The SARS-CoV protein expressed from ORF9b localizes to mitochondria, promotes mitochondrial fusion and modulates the host antiviral defense (
 <xref rid="bib97" ref-type="bibr">Shi et al., 2014</xref>). By increasing ubiquitination and proteasomal degradation of the mitochondrial fission factor DRP1, it favors mitochondrial fusion, possibly promoting cell survival during viral replication. ORF9b furthermore triggers the degradation of MAVS, severely limiting host cell interferon responses (
 <xref rid="bib97" ref-type="bibr">Shi et al., 2014</xref>).
</p>
